How to Align the Moving Parts in Personalized Medicine Reimbursement

Of the many business, operational, legal, regulatory and clinical obstacles standing in the way of widespread delivery of personalized medicine, the single greatest challenge seems to lie in solving the reimbursement puzzle. Advocates of personalized medicine contend that it results in better care for the patient, as therapy is specific to an individual and his or her clinical condition, and that it should also result in cost savings, as treatment that is unlikely to work for that patient is avoided. So if personalized medicine results in better clinical care and reduced costs, why are payers seemingly so reticent to pay for it?

View PDF